Blog|November 9, 2026

A New Brief Report on Low-Dose Sublingual Lithium Ascorbate for PTSD

Dr. Kogan and colleagues describe one patient and propose a trial of low-dose sublingual lithium ascorbate for PTSD.

Angela Gabriel
Written By

Angela Gabriel, MSOM, LAc, SEP

Chinese Medicine Doctor, Somatic Experiencing Practitioner

A New Brief Report on Low-Dose Sublingual Lithium Ascorbate for PTSD

Dr. Mikhail Kogan, our Chief Medical Officer, has co-authored a brief report on sublingual low-dose lithium ascorbate for posttraumatic stress disorder (PTSD). It appears in Current Research in Complementary & Alternative Medicine, with Stephanie Covell and Evan Britton as co-authors. The paper presents the idea as a hypothesis worth testing.

Why lithium

At standard doses, lithium is a long-established psychiatric medication. The authors point to proposed mechanisms that overlap with PTSD biology, including GSK-3 inhibition, BDNF signaling, anti-inflammatory effects and mitochondrial support. They also note that lithium carbonate has a narrow therapeutic window, with kidney and thyroid risks and a need for blood monitoring. That is part of their interest in a much lower dose of a different salt.

The supporting data for lithium ascorbate are preclinical. A 2022 paper in Molecules reported neuroprotective effects in cultured neurons and rodent models. Human data on lithium in PTSD are sparse. One example is a 1995 case report of two veterans treated with lithium carbonate for irritability and angry outbursts.

What the report describes

The paper describes a single adult patient with PTSD and co-occurring pain, mood and sleep problems. After she started lithium ascorbate, she reported improvements in mood, sleep, appetite, and physical tension within days. The authors say these changes had not followed her earlier treatments.

What comes next

The authors propose a randomized controlled trial. They describe it as the first controlled evaluation of this form of lithium for PTSD, and they say positive results could justify larger multicenter studies. Until then, the question stays open.

A note for patients and referring clinicians

GWCIM is a specialist, consultative practice. We work alongside the primary care and specialty care clinicians. If you live with PTSD, please consult your healthcare provider before starting or changing any supplement or medication, including lithium in any form. This article is general information and not medical advice.

To ask about a consultation at GWCIM, visit www.gwcim.com.

Sources:

  1. Kogan M, Covell S, Britton E. Sublingual Low-Dose Lithium Ascorbate for Posttraumatic Stress Disorder. Current Research in Complementary & Alternative Medicine. 2026. https://doi.org/10.29011/2577-2201.100289 (article page: https://www.complementarymedicinejournal.com/article/view/sublingual-low-dose-lithium-ascorbate-for-posttraumatic-stress-disorder)
  2. Torshin IY, et al. Lithium Ascorbate as a Promising Neuroprotector: Fundamental and Experimental Studies of an Organic Lithium Salt. Molecules. 2022;27(7):2253. https://doi.org/10.3390/molecules27072253
  3. Forster PL, et al. Lithium for irritability in post-traumatic stress disorder. J Trauma Stress. 1995;8(1):143-149. https://doi.org/10.1007/BF02105412

Learn about GWCIM (https://www.gwcim.com)

#gwcim #integrativemedicine #integrativemedicineDC #PTSD #TraumaRecovery #ClinicalResearch #lithiumsupplementation #lowdoselithium

A New Brief Report on Low-Dose Sublingual Lithium Ascorbate for PTSD

Search GW Center for Integrative Medicine

Need assistance? Call 202-833-5055